NeuroX1 Company
NeuroX1 is a computational drug design startup building a platform to identify drivers of neurodegenerative/neurological diseases then using Chiron, a propritary generative chemistry platform, designs novel compounds for those diseases.
Total Funding:
1750000.0
Headquarters:
Austin, Texas, United States
Funding Status:
Seed
Last Funding Type:
Seed
Last Funding Date:
2023-03-03
Investors Number:
3.0
Founded Date:
2021-11-18
Industry:
Neurodegenerative disease diagnosis and treatment